[1]
A. Almeida, “Recommendations from a Portuguese Expert Group for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients in Clinical Practice”, Acta Med Port, vol. 32, no. 7-8, pp. 550–557, Aug. 2019.